Stock Alert: Chembio Diagnostics Down As FDA Revokes EUA Of Its Covid-19 Test

Stock Alert: Chembio Diagnostics Down As FDA Revokes EUA Of Its Covid-19 Test

RTTNews

Published

Shares of Chembio Diagnostics, Inc. (CEMI) tanked more than 60% Wednesday morning after the FDA revoked the emergency use authorization (EUA) of the company's Covid-19 antibody test, due to performance concerns with the accuracy of the test.

Full Article